Development of Neuroleptic Malignant Syndrome in a Patient with Lewy Body Dementia after Intramuscular Administration of Paliperidone
Neuroleptic malignant syndrome (NMS) is a potentially fatal diagnosis composed of hyperpyrexia, muscle rigidity, altered mental status, and autonomic instability. This syndrome has significant systemic complications including acute renal failure, rhabdomyolysis, hyperkalemia, and seizure. It is asso...
Saved in:
| Main Authors: | Ho-Man Yeung, Sarah Schmitz, Nino Kvantaliani, Christina Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Neurological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2021/8879333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Audit on Prolactin Monitoring for Patients on Oral/Intramuscular Risperidone and Intramuscular Paliperidone
by: Meekha Suresh
Published: (2025-06-01) -
Dementia with Lewy bodies
by: O. S. Levin, et al.
Published: (2018-11-01) -
Neuroleptic malignant syndrome
by: Mariana Moscovich, et al.
Published: (2011-10-01) -
Neuroleptic Malignant Syndrome and Methylphenidate
by: J Gordon Millichap
Published: (1998-12-01) -
Inflammatory changes in early dementia with Lewy bodies
by: Talene A. Yacoubian, et al.
Published: (2025-08-01)